DUOX2 Inhibitors

Auranofin modulates the redox state within cells by inhibiting thioredoxin reductase, an enzyme involved in cellular antioxidant defenses. DUOX2, as a ROS-generating enzyme, is indirectly inhibited by the disruption of cellular redox balance induced by auranofin. The inhibition of thioredoxin reductase alters the cellular environment in a way that negatively impacts DUOX2 activity, providing an indirect avenue for DUOX2 inhibition.

Methimazole interferes with thyroid peroxidase, an enzyme involved in the iodination of thyroglobulin, a process necessary for thyroid hormone synthesis. As DUOX2 collaborates with thyroid peroxidase in thyroid hormone synthesis, the inhibition of thyroid peroxidase by methimazole indirectly impacts DUOX2 function, providing a mechanism for DUOX2 inhibition through disruption of the overall thyroid hormone synthesis pathway.

Sodium perchlorate acts as a competitive inhibitor of iodide transport, disrupting the supply of iodide for DUOX2-mediated ROS generation. By interfering with the transport of iodide, an essential substrate for DUOX2, sodium perchlorate directly inhibits the enzymatic activity of DUOX2. This inhibition occurs at the initial stages of ROS production, making sodium perchlorate a direct inhibitor of DUOX2 function.

Diphenyl diselenide exhibits antioxidant properties by scavenging reactive oxygen species. Its impact on DUOX2 involves the reduction of oxidative stress within the cellular environment, indirectly inhibiting DUOX2 activity. By mitigating ROS levels, diphenyl diselenide provides an indirect means of DUOX2 inhibition, highlighting its potential as a compound that can modulate the redox balance within cells to negatively impact DUOX2 function.

This compound, also called GKT137831, is a dual inhibitor targeting both NOX4 and DUOX1/2 enzymes. By specifically inhibiting DUOX2, GKT137831 disrupts the production of ROS associated with DUOX2 activity. This compound acts as a direct inhibitor, specifically designed to target DUOX2, offering a pharmacological means to modulate ROS generation through selective inhibition of DUOX2 without affecting other NADPH oxidases.

Thioridazine interferes with DUOX2 function by modulating intracellular calcium levels. DUOX2 activity is calcium-dependent, and thioridazine disrupts this dependency by altering calcium homeostasis. By indirectly impacting the calcium-dependent aspects of DUOX2 activation, thioridazine provides a mechanism for the inhibition of DUOX2-mediated ROS production, representing an indirect inhibitor acting on the regulatory elements of DUOX2 activity.

Fenoldopam inhibits DUOX2 through modulation of the dopamine receptor D1. DUOX2 activity is regulated by dopamine receptor signaling, and fenoldopam, as a selective agonist for the dopamine receptor D1, indirectly inhibits DUOX2 by altering receptor-mediated signaling pathways. This modulation disrupts the regulatory elements governing DUOX2 activity, offering an indirect avenue for the pharmacological inhibition of DUOX2 through targeted receptor signaling.

Mercaptopurine influences DUOX2 indirectly by impacting purine metabolism. DUOX2 activity is associated with purine nucleotide-derived cofactors. Mercaptopurine disrupts purine metabolism, affecting the availability of these cofactors and indirectly inhibiting DUOX2 function. This compound provides a means of DUOX2 inhibition by targeting the metabolic pathways associated with DUOX2 activity, offering a unique avenue for modulating ROS production by DUOX2.

N-Acetyl-L-cysteine (NAC) serves as a precursor of glutathione, a key antioxidant molecule. By replenishing cellular glutathione levels, NAC indirectly inhibits DUOX2 activity by enhancing the cellular antioxidant defense system.